|
1
|
Compérat E and Camparo P: Histological
classification of malignant renal tumours at a time of major
diagnostic and therapeutic changes. Diagn Interv Imaging.
93:221–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramana J: RCDB: Renal Cancer Gene
Database. BMC Res Notes. 5:2462012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta K, Miller JD, Li JZ, Russell MW and
Charbonneau C: Epidemiologic and socioeconomic burden of metastatic
renal cell carcinoma (mRCC): A literature review. Cancer Treat Rev.
34:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stadler WM: Targeted agents for the
treatment of advanced renal cell carcinoma. Cancer. 104:2323–2333.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polyzos A: Activity of SU11248, a
multitargeted inhibitor of vascular endothelial growth factor
receptor and platelet-derived growth factor receptor, in patients
with metastatic renal cell carcinoma and various other solid
tumors. J Steroid Biochem Mol Biol. 108:261–266. 2008. View Article : Google Scholar
|
|
6
|
Atkins MB, Ernstoff MS, Figlin RA,
Flaherty KT, George DJ, Kaelin WG Jr, Kwon ED, Libermann TA,
Linehan WM, McDermott DF, et al: Innovations and challenges in
renal cell carcinoma: Summary statement from the Second Cambridge
Conference. Clin Cancer Res. 13:667s–670s. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Longo R, D'Andrea MR, Sarmiento R, Salerno
F and Gasparini G: Integrated therapy of kidney cancer. Ann Oncol.
18(Suppl 6): vi141–vi148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bagga S, Bracht J, Hunter S, Massirer K,
Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4
miRNAs results in target mRNA degradation. Cell. 122:553–563. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stallings RL: MicroRNA involvement in the
pathogenesis of neuroblastoma: Potential for microRNA mediated
therapeutics. Curr Pharm Des. 15:456–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung M, Mollenkopf HJ, Grimm C, Wagner I,
Albrecht M, Waller T, Pilarsky C, Johannsen M, Stephan C, Lehrach
H, et al: MicroRNA profiling of clear cell renal cell cancer
identifies a robust signature to define renal malignancy. J Cell
Mol Med. 13:3918–3928. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Majid S, Saini S, Dar AA, Hirata H,
Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, et
al: MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal
cancer. Cancer Res. 71:2611–2621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirata H, Hinoda Y, Ueno K, Nakajima K,
Ishii N and Dahiya R: MicroRNA-1826 directly targets beta-catenin
(CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
Carcinogenesis. 33:501–508. 2012. View Article : Google Scholar :
|
|
13
|
Doberstein K, Steinmeyer N, Hartmetz AK,
Eberhardt W, Mittelbronn M, Harter PN, Juengel E, Blaheta R,
Pfeilschifter J and Gutwein P: MicroRNA-145 targets the
metalloprotease ADAM17 and is suppressed in renal cell carcinoma
patients. Neoplasia. 15:218–230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schickel R, Park SM, Murmann AE and Peter
ME: miR-200c regulates induction of apoptosis through CD95 by
targeting FAP-1. Mol Cell. 38:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saini S, Yamamura S, Majid S, Shahryari V,
Hirata H, Tanaka Y and Dahiya R: MicroRNA-708 induces apoptosis and
suppresses tumorigenicity in renal cancer cells. Cancer Res.
71:6208–6219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koo S, Martin GS, Schulz KJ, Ronck M and
Toussaint LG: Serial selection for invasiveness increases
expression of miR-143/miR-145 in glioblastoma cell lines. BMC
Cancer. 12:1432012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma F, Zhang J, Zhong L, Wang L, Liu Y,
Wang Y, Peng L and Guo B: Upregulated microRNA-301a in breast
cancer promotes tumor metastasis by targeting PTEN and activating
Wnt/β-catenin signaling. Gene. 535:191–197. 2014. View Article : Google Scholar
|
|
18
|
Lu L, Xue X, Lan J, Gao Y, Xiong Z, Zhang
H, Jiang W, Song W and Zhi Q: MicroRNA-29a upregulates MMP2 in oral
squamous cell carcinoma to promote cancer invasion and
anti-apoptosis. Biomed Pharmacother. 68:13–19. 2014. View Article : Google Scholar
|
|
19
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu
Y, Li J, Hasina R, Cheng C, Lingen MW, et al: Network modeling
identifies molecular functions targeted by miR-204 to suppress head
and neck tumor metastasis. PLOS Comput Biol. 6:e10007302010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sacconi A, Biagioni F, Canu V, Mori F, Di
Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM,
Germoni S, et al: miR-204 targets Bcl-2 expression and enhances
responsiveness of gastric cancer. Cell Death Dis. 3:e4232012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Sangwan V, Banerjee S, Mackenzie
T, Dudeja V, Li X, Wang H, Vickers SM and Saluja AK: miR-204
mediated loss of Myeloid cell leukemia-1 results in pancreatic
cancer cell death. Mol Cancer. 12:1052013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mikhaylova O, Stratton Y, Hall D, Kellner
E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, et
al: VHL-regulated miR-204 suppresses tumor growth through
inhibition of LC3B-mediated autophagy in renal clear cell
carcinoma. Cancer Cell. 21:532–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wotschofsky Z, Liep J, Meyer HA, Jung M,
Wagner I, Disch AC, Schaser KD, Melcher I, Kilic E, Busch J, et al:
Identification of metastamirs as metastasis-associated microRNAs in
clear cell renal cell carcinomas. Int J Biol Sci. 8:1363–1374.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.
|
|
26
|
Petillo D, Kort EJ, Anema J, Furge KA,
Yang XJ and Teh BT: MicroRNA profiling of human kidney cancer
subtypes. Int J Oncol. 35:109–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chung TK, Lau TS, Cheung TH, Yim SF, Lo
KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, et al: Dysregulation
of microRNA-204 mediates migration and invasion of endometrial
cancer by regulating FOXC1. Int J Cancer. 130:1036–1045. 2012.
View Article : Google Scholar
|
|
28
|
Zhou X, Li L, Su J and Zhang G: Decreased
miR-204 in H. pylori-associated gastric cancer promotes cancer cell
proliferation and invasion by targeting SOX4. PLoS One.
9:e1014572014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma L, Deng X, Wu M, Zhang G and Huang J:
Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and
facilitates invasion of EBV-associated nasopharyngeal carcinoma
cells. FEBS Lett. 588:1562–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew
KP, Wu YL and Zhang S: MiR-373 targeting of the Rab22a oncogene
suppresses tumor invasion and metastasis in ovarian cancer.
Oncotarget. 5:12291–12303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang D, Liu G and Wang K: miR-203 acts as
a tumor suppressor gene in osteosarcoma by regulating RAB22A. PLoS
One. 10:e01322252015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mesa R, Salomón C, Roggero M, Stahl PD and
Mayorga LS: Rab22a affects the morphology and function of the
endocytic pathway. J Cell Sci. 114:4041–4049. 2001.PubMed/NCBI
|
|
33
|
He H, Dai F, Yu L, She X, Zhao Y, Jiang J,
Chen X and Zhao S: Identification and characterization of nine
novel human small GTPases showing variable expressions in liver
cancer tissues. Gene Expr. 10:231–242. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang T, Gilkes DM, Takano N, Xiang L, Luo
W, Bishop CJ, Chaturvedi P, Green JJ and Semenza GL:
Hypoxia-inducible factors and RAB22A mediate formation of
microvesicles that stimulate breast cancer invasion and metastasis.
Proc Natl Acad Sci USA. 111:E3234–E3242. 2014. View Article : Google Scholar : PubMed/NCBI
|
